NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
IRF9
|
ENSG00000213928.4 | interferon regulatory factor 9 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IRF9 | hg19_v2_chr14_+_24630465_24630531 | 0.96 | 2.7e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr21_+_42733870 | 11.09 |
ENST00000330714.3
ENST00000436410.1 ENST00000435611.1 |
MX2
|
myxovirus (influenza virus) resistance 2 (mouse) |
chr21_+_42798094 | 10.78 |
ENST00000398598.3
ENST00000455164.2 ENST00000424365.1 |
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr1_+_79086088 | 8.72 |
ENST00000370751.5
ENST00000342282.3 |
IFI44L
|
interferon-induced protein 44-like |
chr21_+_42798124 | 7.32 |
ENST00000417963.1
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr21_+_42797958 | 6.56 |
ENST00000419044.1
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr14_+_94577074 | 6.41 |
ENST00000444961.1
ENST00000448882.1 ENST00000557098.1 ENST00000554800.1 ENST00000556544.1 ENST00000298902.5 ENST00000555819.1 ENST00000557634.1 ENST00000555744.1 |
IFI27
|
interferon, alpha-inducible protein 27 |
chr21_+_42798158 | 6.26 |
ENST00000441677.1
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr17_+_6659354 | 6.12 |
ENST00000574907.1
|
XAF1
|
XIAP associated factor 1 |
chr12_+_113344582 | 4.80 |
ENST00000202917.5
ENST00000445409.2 ENST00000452357.2 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr17_+_6659153 | 4.04 |
ENST00000441631.1
ENST00000438512.1 ENST00000346752.4 ENST00000361842.3 |
XAF1
|
XIAP associated factor 1 |
chr12_+_113344811 | 3.82 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr19_-_17516449 | 3.73 |
ENST00000252593.6
|
BST2
|
bone marrow stromal cell antigen 2 |
chr12_+_113376157 | 3.35 |
ENST00000228928.7
|
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr14_+_24630465 | 3.23 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chr13_-_43566301 | 3.15 |
ENST00000398762.3
ENST00000313640.7 ENST00000313624.7 |
EPSTI1
|
epithelial stromal interaction 1 (breast) |
chr11_-_615942 | 2.88 |
ENST00000397562.3
ENST00000330243.5 ENST00000397570.1 ENST00000397574.2 |
IRF7
|
interferon regulatory factor 7 |
chr11_-_615570 | 2.73 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr1_+_948803 | 2.73 |
ENST00000379389.4
|
ISG15
|
ISG15 ubiquitin-like modifier |
chr12_+_113376249 | 2.61 |
ENST00000551007.1
ENST00000548514.1 |
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr1_+_79115503 | 2.40 |
ENST00000370747.4
ENST00000438486.1 ENST00000545124.1 |
IFI44
|
interferon-induced protein 44 |
chr4_-_76944621 | 2.08 |
ENST00000306602.1
|
CXCL10
|
chemokine (C-X-C motif) ligand 10 |
chr3_-_146262637 | 1.84 |
ENST00000472349.1
ENST00000342435.4 |
PLSCR1
|
phospholipid scramblase 1 |
chr3_-_146262352 | 1.84 |
ENST00000462666.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr3_-_146262428 | 1.71 |
ENST00000486631.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr10_+_91092241 | 1.68 |
ENST00000371811.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr3_-_122283100 | 1.67 |
ENST00000492382.1
ENST00000462315.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr3_-_122283079 | 1.61 |
ENST00000471785.1
ENST00000466126.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr9_-_32526184 | 1.58 |
ENST00000545044.1
ENST00000379868.1 |
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr3_-_122283424 | 1.47 |
ENST00000477522.2
ENST00000360356.2 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr3_-_146262365 | 1.43 |
ENST00000448787.2
|
PLSCR1
|
phospholipid scramblase 1 |
chr3_-_146262488 | 1.41 |
ENST00000487389.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr19_+_16254488 | 1.40 |
ENST00000588246.1
ENST00000593031.1 |
HSH2D
|
hematopoietic SH2 domain containing |
chr18_+_13382553 | 1.39 |
ENST00000586222.1
|
LDLRAD4
|
low density lipoprotein receptor class A domain containing 4 |
chr9_+_5510558 | 1.23 |
ENST00000397747.3
|
PDCD1LG2
|
programmed cell death 1 ligand 2 |
chr17_+_6658878 | 1.12 |
ENST00000574394.1
|
XAF1
|
XIAP associated factor 1 |
chr15_+_74287035 | 1.10 |
ENST00000395132.2
ENST00000268059.6 ENST00000354026.6 ENST00000268058.3 ENST00000565898.1 ENST00000569477.1 ENST00000569965.1 ENST00000567543.1 ENST00000436891.3 ENST00000435786.2 ENST00000564428.1 ENST00000359928.4 |
PML
|
promyelocytic leukemia |
chr17_-_54991369 | 1.08 |
ENST00000537230.1
|
TRIM25
|
tripartite motif containing 25 |
chr6_+_106546808 | 1.08 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
chr2_-_163175133 | 0.98 |
ENST00000421365.2
ENST00000263642.2 |
IFIH1
|
interferon induced with helicase C domain 1 |
chr2_+_33701684 | 0.98 |
ENST00000442390.1
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
chr2_-_7005785 | 0.97 |
ENST00000256722.5
ENST00000404168.1 ENST00000458098.1 |
CMPK2
|
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
chr16_-_74734672 | 0.96 |
ENST00000306247.7
ENST00000575686.1 |
MLKL
|
mixed lineage kinase domain-like |
chr6_+_126240442 | 0.95 |
ENST00000448104.1
ENST00000438495.1 ENST00000444128.1 |
NCOA7
|
nuclear receptor coactivator 7 |
chr3_+_122283175 | 0.90 |
ENST00000383661.3
|
DTX3L
|
deltex 3-like (Drosophila) |
chr3_-_130745403 | 0.85 |
ENST00000504725.1
ENST00000509060.1 |
ASTE1
|
asteroid homolog 1 (Drosophila) |
chr9_-_32526299 | 0.83 |
ENST00000379882.1
ENST00000379883.2 |
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr1_+_59486059 | 0.81 |
ENST00000447329.1
|
RP4-794H19.4
|
RP4-794H19.4 |
chr18_-_67624412 | 0.79 |
ENST00000580335.1
|
CD226
|
CD226 molecule |
chr9_+_74764278 | 0.76 |
ENST00000238018.4
ENST00000376989.3 |
GDA
|
guanine deaminase |
chr11_-_57334732 | 0.75 |
ENST00000526659.1
ENST00000527022.1 |
UBE2L6
|
ubiquitin-conjugating enzyme E2L 6 |
chr3_+_122283064 | 0.71 |
ENST00000296161.4
|
DTX3L
|
deltex 3-like (Drosophila) |
chr11_-_67141090 | 0.70 |
ENST00000312438.7
|
CLCF1
|
cardiotrophin-like cytokine factor 1 |
chr6_-_32806483 | 0.70 |
ENST00000374899.4
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
chr8_-_27941380 | 0.68 |
ENST00000413272.2
ENST00000341513.6 |
NUGGC
|
nuclear GTPase, germinal center associated |
chr19_+_17516531 | 0.67 |
ENST00000528911.1
ENST00000528604.1 ENST00000595892.1 ENST00000500836.2 ENST00000598546.1 ENST00000600369.1 ENST00000598356.1 ENST00000594426.1 |
MVB12A
CTD-2521M24.9
|
multivesicular body subunit 12A CTD-2521M24.9 |
chr3_-_146262293 | 0.64 |
ENST00000448205.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr11_-_57335280 | 0.62 |
ENST00000287156.4
|
UBE2L6
|
ubiquitin-conjugating enzyme E2L 6 |
chr1_-_150738261 | 0.62 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
chr17_-_54991395 | 0.60 |
ENST00000316881.4
|
TRIM25
|
tripartite motif containing 25 |
chr17_+_41363854 | 0.59 |
ENST00000588693.1
ENST00000588659.1 ENST00000541594.1 ENST00000536052.1 ENST00000331615.3 |
TMEM106A
|
transmembrane protein 106A |
chr15_+_74287118 | 0.58 |
ENST00000563500.1
|
PML
|
promyelocytic leukemia |
chr3_+_187086120 | 0.58 |
ENST00000259030.2
|
RTP4
|
receptor (chemosensory) transporter protein 4 |
chr9_+_5510492 | 0.57 |
ENST00000397745.2
|
PDCD1LG2
|
programmed cell death 1 ligand 2 |
chr18_-_67624160 | 0.57 |
ENST00000581982.1
ENST00000280200.4 |
CD226
|
CD226 molecule |
chr2_-_152118276 | 0.56 |
ENST00000409092.1
|
RBM43
|
RNA binding motif protein 43 |
chr6_-_110736742 | 0.55 |
ENST00000368924.3
ENST00000368923.3 |
DDO
|
D-aspartate oxidase |
chr4_-_169401628 | 0.52 |
ENST00000514748.1
ENST00000512371.1 ENST00000260184.7 ENST00000505890.1 ENST00000511577.1 |
DDX60L
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like |
chr6_-_31324943 | 0.51 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
chr3_-_121379739 | 0.51 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
chr17_-_40264692 | 0.49 |
ENST00000591220.1
ENST00000251642.3 |
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58 |
chr19_+_17516494 | 0.48 |
ENST00000534306.1
|
CTD-2521M24.9
|
CTD-2521M24.9 |
chr13_+_50070491 | 0.48 |
ENST00000496612.1
ENST00000357596.3 ENST00000485919.1 ENST00000442195.1 |
PHF11
|
PHD finger protein 11 |
chr12_-_56753858 | 0.47 |
ENST00000314128.4
ENST00000557235.1 ENST00000418572.2 |
STAT2
|
signal transducer and activator of transcription 2, 113kDa |
chr3_+_122399444 | 0.45 |
ENST00000474629.2
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14 |
chr9_+_74764340 | 0.45 |
ENST00000376986.1
ENST00000358399.3 |
GDA
|
guanine deaminase |
chr19_+_17516909 | 0.44 |
ENST00000601007.1
ENST00000594913.1 ENST00000599975.1 ENST00000600514.1 |
CTD-2521M24.9
MVB12A
|
CTD-2521M24.9 multivesicular body subunit 12A |
chr11_-_86383650 | 0.44 |
ENST00000526944.1
ENST00000530335.1 ENST00000543262.1 ENST00000524826.1 |
ME3
|
malic enzyme 3, NADP(+)-dependent, mitochondrial |
chr2_-_37384175 | 0.43 |
ENST00000411537.2
ENST00000233057.4 ENST00000395127.2 ENST00000390013.3 |
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2 |
chr5_-_59481406 | 0.40 |
ENST00000546160.1
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
chr13_+_50070077 | 0.37 |
ENST00000378319.3
ENST00000426879.1 |
PHF11
|
PHD finger protein 11 |
chr12_-_121476959 | 0.35 |
ENST00000339275.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr1_-_154580616 | 0.33 |
ENST00000368474.4
|
ADAR
|
adenosine deaminase, RNA-specific |
chr6_-_32806506 | 0.33 |
ENST00000374897.2
ENST00000452392.2 |
TAP2
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) Uncharacterized protein |
chr7_+_18535893 | 0.33 |
ENST00000432645.2
ENST00000441542.2 |
HDAC9
|
histone deacetylase 9 |
chr3_-_141747439 | 0.30 |
ENST00000467667.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr12_+_113344755 | 0.29 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr2_-_106810783 | 0.29 |
ENST00000283148.7
|
UXS1
|
UDP-glucuronate decarboxylase 1 |
chr17_-_4167142 | 0.28 |
ENST00000570535.1
ENST00000574367.1 ENST00000341657.4 ENST00000433651.1 |
ANKFY1
|
ankyrin repeat and FYVE domain containing 1 |
chr1_+_241695424 | 0.27 |
ENST00000366558.3
ENST00000366559.4 |
KMO
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
chr15_+_74287009 | 0.24 |
ENST00000395135.3
|
PML
|
promyelocytic leukemia |
chr17_-_74489215 | 0.24 |
ENST00000585701.1
ENST00000591192.1 ENST00000589526.1 |
RHBDF2
|
rhomboid 5 homolog 2 (Drosophila) |
chr8_+_39770803 | 0.23 |
ENST00000518237.1
|
IDO1
|
indoleamine 2,3-dioxygenase 1 |
chr3_-_28390120 | 0.23 |
ENST00000334100.6
|
AZI2
|
5-azacytidine induced 2 |
chr3_+_122399697 | 0.23 |
ENST00000494811.1
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14 |
chr15_-_26108355 | 0.23 |
ENST00000356865.6
|
ATP10A
|
ATPase, class V, type 10A |
chr2_-_220252068 | 0.21 |
ENST00000430206.1
ENST00000429013.1 |
DNPEP
|
aspartyl aminopeptidase |
chr1_+_66820058 | 0.20 |
ENST00000480109.2
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr17_+_38296576 | 0.20 |
ENST00000264645.7
|
CASC3
|
cancer susceptibility candidate 3 |
chr17_+_54230819 | 0.19 |
ENST00000318698.2
ENST00000566473.2 |
ANKFN1
|
ankyrin-repeat and fibronectin type III domain containing 1 |
chr11_-_4414880 | 0.19 |
ENST00000254436.7
ENST00000543625.1 |
TRIM21
|
tripartite motif containing 21 |
chr15_+_91643442 | 0.17 |
ENST00000394232.1
|
SV2B
|
synaptic vesicle glycoprotein 2B |
chr12_-_121477039 | 0.17 |
ENST00000257570.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr2_+_33701707 | 0.17 |
ENST00000425210.1
ENST00000444784.1 ENST00000423159.1 |
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
chr9_+_70971815 | 0.16 |
ENST00000396392.1
ENST00000396396.1 |
PGM5
|
phosphoglucomutase 5 |
chr18_-_67623906 | 0.15 |
ENST00000583955.1
|
CD226
|
CD226 molecule |
chr11_-_86383157 | 0.15 |
ENST00000393324.3
|
ME3
|
malic enzyme 3, NADP(+)-dependent, mitochondrial |
chr2_-_106810742 | 0.15 |
ENST00000409501.3
ENST00000428048.2 ENST00000441952.1 ENST00000457835.1 ENST00000540130.1 |
UXS1
|
UDP-glucuronate decarboxylase 1 |
chrX_-_48858630 | 0.14 |
ENST00000376425.3
ENST00000376444.3 |
GRIPAP1
|
GRIP1 associated protein 1 |
chr16_+_28962128 | 0.14 |
ENST00000564978.1
ENST00000320805.4 |
NFATC2IP
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 interacting protein |
chr6_-_33282024 | 0.13 |
ENST00000475304.1
ENST00000489157.1 |
TAPBP
|
TAP binding protein (tapasin) |
chr3_-_27764190 | 0.13 |
ENST00000537516.1
|
EOMES
|
eomesodermin |
chr2_-_220252530 | 0.12 |
ENST00000521459.1
|
DNPEP
|
aspartyl aminopeptidase |
chr6_+_37400974 | 0.11 |
ENST00000455891.1
ENST00000373451.4 |
CMTR1
|
cap methyltransferase 1 |
chr5_-_95297678 | 0.10 |
ENST00000237853.4
|
ELL2
|
elongation factor, RNA polymerase II, 2 |
chr6_+_72922590 | 0.08 |
ENST00000523963.1
|
RIMS1
|
regulating synaptic membrane exocytosis 1 |
chr1_-_234667504 | 0.08 |
ENST00000421207.1
ENST00000435574.1 |
RP5-855F14.1
|
RP5-855F14.1 |
chr18_+_42260861 | 0.08 |
ENST00000282030.5
|
SETBP1
|
SET binding protein 1 |
chr6_+_72922505 | 0.07 |
ENST00000401910.3
|
RIMS1
|
regulating synaptic membrane exocytosis 1 |
chrX_-_48858667 | 0.07 |
ENST00000376423.4
ENST00000376441.1 |
GRIPAP1
|
GRIP1 associated protein 1 |
chr22_+_40297079 | 0.06 |
ENST00000344138.4
ENST00000543252.1 |
GRAP2
|
GRB2-related adaptor protein 2 |
chr4_-_147442982 | 0.06 |
ENST00000511374.1
ENST00000264986.3 |
SLC10A7
|
solute carrier family 10, member 7 |
chr19_-_12807422 | 0.06 |
ENST00000380339.3
ENST00000544494.1 ENST00000393261.3 |
FBXW9
|
F-box and WD repeat domain containing 9 |
chr1_+_162602244 | 0.05 |
ENST00000367922.3
ENST00000367921.3 |
DDR2
|
discoidin domain receptor tyrosine kinase 2 |
chr6_-_33281979 | 0.03 |
ENST00000426633.2
ENST00000467025.1 |
TAPBP
|
TAP binding protein (tapasin) |
chr16_-_15736881 | 0.03 |
ENST00000540441.2
|
KIAA0430
|
KIAA0430 |
chr14_+_100531615 | 0.02 |
ENST00000392920.3
|
EVL
|
Enah/Vasp-like |
chr1_-_207119738 | 0.02 |
ENST00000356495.4
|
PIGR
|
polymeric immunoglobulin receptor |
chr19_+_10196981 | 0.02 |
ENST00000591813.1
|
C19orf66
|
chromosome 19 open reading frame 66 |
chr17_+_7211656 | 0.02 |
ENST00000416016.2
|
EIF5A
|
eukaryotic translation initiation factor 5A |
chr3_-_28390415 | 0.00 |
ENST00000414162.1
ENST00000420543.2 |
AZI2
|
5-azacytidine induced 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 42.0 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
1.4 | 5.6 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
1.2 | 3.7 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
0.9 | 8.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.7 | 3.4 | GO:0035549 | positive regulation of interferon-beta secretion(GO:0035549) |
0.5 | 6.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.4 | 1.2 | GO:0006147 | guanine catabolic process(GO:0006147) |
0.4 | 4.7 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.4 | 1.1 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.3 | 1.0 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.3 | 3.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 9.7 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 1.5 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
0.2 | 1.0 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.2 | 1.9 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 2.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 17.0 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.2 | 1.1 | GO:0019075 | virus maturation(GO:0019075) |
0.1 | 0.4 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.1 | 1.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 1.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 1.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 1.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.7 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.1 | 0.1 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.1 | 0.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.5 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.2 | GO:0036269 | swimming behavior(GO:0036269) |
0.0 | 0.4 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.0 | 0.1 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.0 | 1.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.6 | GO:1901898 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.1 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.0 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.3 | GO:0048549 | endosome localization(GO:0032439) positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 1.0 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.2 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.0 | 0.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 1.2 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.0 | 0.6 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 6.1 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.7 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.2 | 1.2 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.6 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 37.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 11.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.2 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.1 | 1.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 3.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 1.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 1.0 | GO:0012505 | endomembrane system(GO:0012505) |
0.0 | 8.4 | GO:0045121 | membrane raft(GO:0045121) |
0.0 | 0.5 | GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.0 | 2.1 | GO:0032587 | ruffle membrane(GO:0032587) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 14.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.5 | 2.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 8.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.4 | 1.2 | GO:0008892 | guanine deaminase activity(GO:0008892) |
0.2 | 1.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.2 | 1.2 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
0.2 | 2.9 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 5.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 6.4 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 3.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 42.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.6 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.1 | 0.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 1.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 1.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.0 | 4.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 1.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.8 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 1.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 2.9 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 3.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 1.9 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 9.4 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.6 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 1.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.3 | GO:0031078 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 1.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 1.9 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 5.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 2.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 3.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 87.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 5.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 0.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 2.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 1.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 1.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |